Explore Ledisa's GLP-1 Support Patches and see how simple it is to make them a consistent part of your day
Conversely, initial concerns on the risk of pancreatic cancer have not been confirmed
Semaglutide, a second-generation GLP-1 agonist, achieved around 14% total body weight loss in clinical trials, while tirzepatide, a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, has demonstrated even more impressive results, with average weight loss reaching 22.5%
The drugs, typically taken once weekly as injections, work by helping the pancreas increase the production of insulin to move sugar from the blood into body tissues
N., Savage, M
These include: Blood glucose readings above your target range, especially if over 300 mg/dL Increased thirst and urination Unexplained fatigue or weakness Fruity-smelling breath Nausea or vomiting (which may indicate hyperglycemia rather than medication side effects) Seek urgent care if your blood glucose is above 300 mg/dL or above 250 mg/dL with moderate to large ketones, if you have persistent vomiting, inability to keep fluids down, confusion, or signs of dehydration
